[HTML][HTML] Cardiac biomarkers and COVID-19: A systematic review and meta-analysis

W An, JS Kang, Q Wang, TE Kim - Journal of Infection and Public Health, 2021 - Elsevier
Objective To systematically investigate the relationship between cardiac biomarkers and
COVID-19 severity and mortality. Methods We performed a literature search using PubMed …

[HTML][HTML] Effects of antimalarial drugs on neuroinflammation-potential use for treatment of COVID-19-related neurologic complications

WY Ong, ML Go, DY Wang, IKM Cheah… - Molecular …, 2021 - Springer
The SARS-CoV-2 virus that is the cause of coronavirus disease 2019 (COVID-19) affects not
only peripheral organs such as the lungs and blood vessels, but also the central nervous …

[HTML][HTML] A review of cardiac troponin I detection by surface enhanced Raman spectroscopy: Under the spotlight of point-of-care testing

AI Saviñon-Flores, F Saviñon-Flores, G Trejo… - Frontiers in …, 2022 - frontiersin.org
Cardiac troponin I (cTnI) is a biomarker widely related to acute myocardial infarction (AMI),
one of the leading causes of death around the world. Point-of-care testing (POCT) of cTnI not …

[HTML][HTML] COVID-19 is more dangerous for older people and its severity is increasing: a case-control study

C Mertoglu, MT Huyut, H Olmez, M Tosun… - Medical gas …, 2022 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19) triggers important changes in routine blood
tests. In this retrospective case-control study, biochemical, hematological and inflammatory …

[HTML][HTML] Possible correlations between atherosclerosis, acute coronary syndromes and COVID-19

O Grzegorowska, J Lorkowski - Journal of Clinical Medicine, 2020 - mdpi.com
An outbreak of SARS-CoV-2 infection in December 2019 became a major global concern in
2020. Since then, several articles analyzing the course, complications and mechanisms of …

[HTML][HTML] Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: Opportunities and challenges

R Mittal, N Chourasia, VK Bharti, S Singh… - Journal of Family …, 2022 - journals.lww.com
The reasons for high morbidity and mortality with Corona virus disease (COVID-19) disease
remain unanswered with extremes of manifestation and uncertainty of modes of …

[HTML][HTML] The novel perspectives opened by ST2 in the pandemic: a review of its role in the diagnosis and prognosis of patients with heart failure and COVID-19

RS Miftode, AO Petriș, V Onofrei Aursulesei, C Cianga… - Diagnostics, 2021 - mdpi.com
The increasing incidence of coronavirus disease 19 (COVID-19) and its polymorphic clinical
manifestations due to local and systemic inflammation represent a high burden for many …

[HTML][HTML] COVID-19 and coronary artery disease; a systematic review and meta-analysis

B Hajikhani, M Safavi, N Bostanshirin, F Sameni… - New Microbes and New …, 2023 - Elsevier
Background and aim Patients with underlying cardiovascular disorders such as coronary
artery disease (CAD) are more prone to severe forms and multiple complications of COVID …

[HTML][HTML] Optimal cut points of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) in patients with COVID-19

M Chehrazi, H Yavarpour, F Jalali, M Saravi… - The Egyptian Heart …, 2022 - Springer
Background COVID19 patients may suffer from multiple cardiovascular complications.
Recently, N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) was a …

[HTML][HTML] Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19: A multicenter, observational study

J Yang, X Liao, W Yin, B Wang, J Yue, L Bai… - The American Journal of …, 2021 - Elsevier
Purpose The coronavirus disease 19 (COVID-19) has become a global health event.
Cardiac biomarkers like creatine kinase isoenzyme (CK-MB), myoglobin, and high …